Promoting oral potassium administration in a tertiary care hospital: An eleven-year study

McLeod, 2013, Methodological variations and their effects on reported medication administration error rates, BMJ Qual Saf, 22, 278, 10.1136/bmjqs-2012-001330 Keers, 2015, Understanding the causes of intravenous medication administration errors in hospitals: a qualitative critical incident study, BMJ Open, 13, e005948, 10.1136/bmjopen-2014-005948 Ofek, 2016, Introducing a change in hospital policy using FMEA methodology as a tool to reduce patient hazards, Isr J Health Policy Res, 5, 30, 10.1186/s13584-016-0090-7 Kim, 2002, Therapeutic approach to hypokalemia, Nephron, 92, 28, 10.1159/000065374 Swanson, 2003, Implementing an IV potassium policy, Hosp Pharm, 10, 348 Rhoda, 2011, Fluid and electrolyte management: putting a plan in motion, J Parenter Enteral Nutr, 35, 675, 10.1177/0148607111421913 Levene, 1973, Potassium chloride: absorption and excretion, Can Med Assoc J, 108, 853 Lowance, 1982, Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement, Int J Clin Pharmacol Ther Toxicol, 20, 204 Toner, 1985, Pharmacokinetics of potassium chloride in wax-based and syrup formulations, Br J Clin Pharmacol, 19, 489, 10.1111/j.1365-2125.1985.tb02674.x Melikian, 1988, Bioavailability of potassium from three dosage forms: suspension, capsule, and solution, J Clin Pharmacol, 28, 1046, 10.1002/j.1552-4604.1988.tb03128.x Kuper, 2008, Intravenous to oral conversion therapy Charpiat, 2014, Pharmacists’ interventions on intravenous to oral conversion for potassium, Int J Clin Pharm, 36, 513, 10.1007/s11096-014-9916-y Agence nationale de sécurité du médicament et des produits de santé (ANSM), 2011 Hemstreet, 2006, Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety, Curr Med Res Opin, 22, 2449, 10.1185/030079906X148463 DeCarolis, 2016, Comparative dose response using the intravenous versus enteral route of administration for potassium replenishment, Intensive Crit Care Nurs, 36, 17, 10.1016/j.iccn.2015.08.005 Charpiat, 2013, Overdosed paracetamol (acetaminophen) prescriptions and subsequent pharmacist interventions in French hospitals, Ann Pharm Fr, 71, 410, 10.1016/j.pharma.2013.08.010 Bloom, 2005, Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews, Int J Technol Assess Health Care, 21, 380, 10.1017/S026646230505049X Ostini, 2011, How is medication prescribing ceased? A systematic review, Med Care, 49, 24, 10.1097/MLR.0b013e3181ef9a7e Stammen, 2015, Training physicians to provide high-value, cost-conscious care: a systematic review, JAMA, 314, 2384, 10.1001/jama.2015.16353 Bülow, 2018, Important aspects of pharmacist-led medication reviews in an acute medical ward, Basic Clin Pharmacol Toxicol, 122, 253, 10.1111/bcpt.12901 Brehaut, 2016, Practice feedback interventions: 15 suggestions for optimizing effectiveness, Ann Intern Med, 164, 435, 10.7326/M15-2248 Cyriac, 2014, Switch over from intravenous to oral therapy: a concise overview, J Pharmacol Pharmacother, 5, 83, 10.4103/0976-500X.130042 Colombet, 2009, Long-term effects of a multifaceted intervention to encourage the choice of the oral route for proton pump inhibitors: an interrupted time-series analysis, Qual Saf Health Care, 18, 232, 10.1136/qshc.2007.023887 Thompson, 2015, The use of an IV to PO clinical intervention form to improve antibiotic administration in a community based hospital, BMJ Qual Improv Rep, 4, 10.1136/bmjquality.u200786.w2247 Ministère du travail de l’emploi et de la santé, 2011, Arrêté du 6 avril 2011 relatif au management de la qualité de la prise en charge médicamenteuse et aux médicaments dans les établissements de santé, JORF Agence nationale de sécurité du médicament et des produits de santé (ANSM), 2011 Schmitt, 1999, Le risque médicamenteux nosocomial: circuit hospitalier du médicament et qualité des soins 2009 Théophile, 2011, Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration, Eur J Clin Pharmacol, 67, 681, 10.1007/s00228-011-1055-y Gerlach, 2018, Assessing responsiveness of health systems to drug safety warnings, Am J Geriatr Psychiatry, 26, 476, 10.1016/j.jagp.2017.09.024 Arenz, 2016, Effectively implementing FDA medication alerts utilizing patient centered medical home clinical pharmacists, Healthc (Amst), 4, 69, 10.1016/j.hjdsi.2015.07.001 Corny, 2017, Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch, J Eval Clin Pract, 23, 848, 10.1111/jep.12728 van Niekerk, 2012, Implementation of intravenous to oral antibiotic switch therapy guidelines in the general medical wards of a tertiary-level hospital in South Africa, J Antimicrob Chemother, 67, 756, 10.1093/jac/dkr526 World Health Organization, 2007, Collaborating centre for patient safety solutions. Control of concentrated electrolyte solutions Cousins, 2005, Potassium chloride issues needs further clarification, BMJ Zhu, 2016, Quality improvements in potassium replenishment in intensive critical care units, Intensive Crit Care Nurs, 36, 24, 10.1016/j.iccn.2016.03.005 Li, 2015, An unsupported preference for intravenous antibiotics, PLoS Med, 12, e1001825, 10.1371/journal.pmed.1001825 Kane-Gill, 2012, Analysis of risk factors for adverse drug events in critically ill patients, Crit Care Med, 40, 823, 10.1097/CCM.0b013e318236f473